Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00920023
What this trial is testing

Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 35
Not applicableStudy completedNCT06093009
What this trial is testing

The Significance of Postoperative Muscle Wasting in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Cheng-Kung University Hospital 208
Testing effectiveness (Phase 2)WithdrawnNCT06110598
What this trial is testing

CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)

Who this might be right for
Pancreas CancerPancreas Adenocarcinoma
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT01360853
What this trial is testing

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Traws Pharma, Inc. 160
Not applicableStudy completedNCT03203434
What this trial is testing

Non-invasive Detection of Anastomotic Leakage

Who this might be right for
Anastomotic Leak
Amsterdam UMC, location VUmc 66
Testing effectiveness (Phase 2)Study completedNCT02370537
What this trial is testing

Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI

Who this might be right for
Diabetes Mellitus, Type 2Exocrine Pancreatic Insufficiency
AstraZeneca 490
Not applicableStudy completedNCT05644730
What this trial is testing

Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Ideal Medical Technologies 7
Not applicableUnknownNCT06499792
What this trial is testing

Effectiveness of the Transversus Abdominis Plane Block Associated With Opioid Spinal Anesthesia on Analgesia After Cephalic Duodenopancreatectomy

Who this might be right for
Pancreatic Cancer
University Hospital, Strasbourg, France 160
Testing effectiveness (Phase 2)Study completedNCT01553019
What this trial is testing

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Florida 2
Early research (Phase 1)Ended earlyNCT02687230
What this trial is testing

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

Who this might be right for
Pancreatic CarcinomaTumors That Express CA19-9
BioNTech Research & Development, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT02352831
What this trial is testing

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerCancer of PancreasCancer of the Pancreas+1 more
Washington University School of Medicine 16
Not applicableLooking for participantsNCT06706700
What this trial is testing

Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas

Who this might be right for
Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Cyst
IRCCS San Raffaele 586
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Very early researchEnded earlyNCT04930991
What this trial is testing

High Dose Omeprazole in Patients With Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Cancer
University of Oklahoma 25
Not applicableLooking for participantsNCT07591246
What this trial is testing

Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction

Who this might be right for
Polycystic Ovary SyndromeNon-Alcoholic Fatty Pancreatic DiseaseSubclinical hypothyroïdism
Cairo University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Not applicableUnknownNCT02220062
What this trial is testing

Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer

Who this might be right for
Pancreatic Neoplasms
Samsung Medical Center 166
Early research (Phase 1)UnknownNCT04425876
What this trial is testing

Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 74
Not applicableStudy completedNCT07147374
What this trial is testing

Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyRobotic Surgery
Peking Union Medical College Hospital 56
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Next Page